CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

41

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

Tags:

Previous Article

The maternal microbiome during pregnancy impacts offspring’s stem cells in mice

CAR-T cells for multiple sclerosis

Related Posts

PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells

PMP22 duplication dysregulates lipid homeostasis and pl...

35

Metacognition in the listening brain

Metacognition in the listening brain

56

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Im...

45